Fighting the Ghosts

| Wed Aug. 19, 2009 1:51 AM EDT

An awful lot of journal articles supposedly written by medical researchers are actually written by pharmaceutical company PR departments.  Someone is finally starting to do something about it:

With a letter last week, a senator who helps oversee public funding for medical research signaled that he was running out of patience with the practice of ghostwriting. Senator Charles E. Grassley, an Iowa Republican who has led a long-running investigation of conflicts of interest in medicine, is starting to put pressure on the National Institutes of Health to crack down on the practice.

....The full scope of the ghostwriting problem is still unclear, but recent revelations suggest that the practice is widespread. Dozens of medical education companies across the country draft scientific papers at the behest of drug makers. And placing such papers in medical journals has become a fundamental marketing practice for most of the large pharmaceutical companies.

“Just three days ago, I got a request to be the author of a ghostwritten article about the effectiveness of a cholesterol-lowering drug,” Dr. James H. Stein, professor of cardiology at the University of Wisconsin School of Medicine, said this month. “This happens all the time.” He declined to attach his name to the paper.

Grassley's a weird dude, and he's been notably unhelpful on the healthcare reform effort.  But at least he's not completely worthless.  Good for him for taking this on.

Get Mother Jones by Email - Free. Like what you're reading? Get the best of MoJo three times a week.